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Air pollutants have serious health effects on human beings. 
The 2010 Global Burden of Disease study reports that each 
year, ambient particulate matter (PM2.5, particles with aero-
dynamic diameter < 2.5 micrometer) is causing 3.2 million 
premature deaths globally, and 1.2 million in China alone. 
Ambient PM pollution ranked fourth among all risk factors 
in China [1]. 
Although the association of PM2.5 exposure with prema-
ture deaths from lung cancer, chronic obstructive pulmonary 
disease (COPD), ischemic heart disease (IHD) and cere-
brovascular disease are well documented, there is growing 
evidence that PM2.5 exposure in ambient air has health ef-
fects on the brain, reproduction, immune system, and me-
tabolism. However, the underlying mechanism for such 
effects is complicated, with various hypothetical pathways 
proposed. It is generally believed that oxidative stress and 
pulmonary inflammation are direct effects of PM2.5 particles, 
which in turn lead to systematic inflammation and endothe-
lial dysfunction, automatic nervous system imbalance, and 
others [2]. Substantial evidence from toxicological and epi-
demiological studies has accumulated to reveal the mecha-
nism of the PM2.5 health effects, but this evidence is fre-
quently inconsistent and at times even contradictory.  
To address the complicated nature of PM2.5 health effects, 
one needs to consider both those effects and PM character-
istics simultaneously, e.g., time after exposure (lag effects), 
particle size and chemical composition, and susceptible 
populations. Here, we suggest that these variables compose 
four dimensions that are necessary to describe the PM2.5 
health effects and their underlying mechanism (Figure 1). 
Time after exposure (Lag effect). Health effects of air 
pollution represent a continuous pathophysiological process, 
evolving from acute to chronic effects. The order of this 
process may be described as external exposure, internal 
exposure, change in subclinical biomarkers, change in func-
tion/clinical endpoints, disease, and death. Based on differ-
ence in research purpose and design, selected health end-
points and related observation time windows of the effects 
vary. For example, panel and controlled exposure studies 
focus on subclinical biomarkers and functional change, such 
as inflammatory cytokines in serum or altered heart rate 
variability (HRV). Therefore, the observed lag effect may 
be from hours to days. Time-series studies have examined 
acute effects using clinical visits, hospitalization rates, or 
mortality as endpoints, with time windows from days to 
weeks [3]. Cohort and cross-sectional studies usually aim at 
chronic effects after years or even decades-long air pollu-
tion exposure, using morbidity/mortality of chronic disease 
and life expectancy as health endpoints. 
Researches on the health effects of air pollution in China 
have mainly been based on time-series studies. Cohort and 
panel studies are limited, and no prospective cohort study 
has been reported. In addition to strength of causality, co-
hort studies in China can provide specific exposure-    
response relationships at concentration levels observed in 
most Chinese cities (e.g., annual mean PM2.5 concentrations 
50–100 g m3). This could furnish much greater accuracy 
in the estimation of premature death caused by air pollution. 
Panel studies would enhance understanding of the mecha-
nisms underlying health effects, identification of spe-
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Figure 1  Four dimensions required to describe health effects of fine particles on human subjects, i.e., time after exposure, size and composition of fine 
particles, and susceptible populations. 
cific air components of PM2.5 that generate those effects, 
and identify representative biomarkers in the early phase of 
the effects. 
Size effect of fine particles. Size distribution is an im-
portant characterization of particles in ambient air. Particles 
of varying aerodynamic size indicate differences not only in 
their compositions and sources but also related health ef-
fects. 
According to the aerodynamic behavior of size-     
segregated particles in the human respiratory tract, a predic-
tive mathematical model, the multiple path particle dosime-
try model, was developed by the International Commission 
on Radiological Protection to estimate the deposition of 
inhaled particles of various size in the head/nasopharyngeal, 
tracheobronchial, and pulmonary/alveolar regions of the 
respiratory tract [4]. Results show that for particles with 
diameters of 20–100 nm, deposition efficiency in the deep 
pulmonary section increases with decreasing particle size. 
That is, smaller particles are more likely to be deposited in 
that section, contact epithelial cells and macrophages, caus-
ing subsequent inflammation. 
Toxicological studies have also provided evidence that 
particles of smaller size were cleared slower than larger 
ones, and are thereby retained longer within the lung after 
deposition. Particles of size less than 100 nm may have the 
ability to cross the air-blood barrier in the alveolar and enter 
the cardiovascular system. In addition, such particles have a 
larger active surface area, which tends to absorb more toxic 
chemicals. Some time-series studies support the hypothesis 
that smaller particles have greater health effects, but results 
are inconsistent. Number concentration and specific compo-
sition of size-segregated particles in ambient air should also 
be considered. Moreover, population-based studies focused 
on the effect of size-segregated particles on comprehensive 
biomarkers are still lacking.  
Component effect of fine particles. Toxicological studies 
have proven that certain compositions of particles have a 
stronger toxicity than others, e.g., transition metal, carbo-
naceous components, polycyclic aromatic hydrocarbons, 
and quinones-like matters. Microbial components in parti-
cles have also been identified as potential risk factors in 
human health. Although some evidence from epidemiolog-
ical studies supports the hypothesis that particle health ef-
fects are attributable to certain components, there have been 
no consistent conclusions. The mass concentration of PM 
(e.g., PM2.5) remains the most robust indicator of health 
impacts. 
The inconsistency in the population-based research may 
be attributed to the following reasons. First, despite the spa-
tial uniformity of PM2.5 concentration in the subject region,  
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certain components may have inhomogeneous spatial dis-
tributions. For instance, transition metal and carbonaceous 
components vary because of local source emissions, so us-
ing single-site monitoring data in a population-based study 
could lead to exposure misclassification. Second, PM health 
effects in ambient air are not simply additive effects of the 
toxicological results of various components, but more likely 
a combination of additive, synergistic, and antagonistic ef-
fects. Third, evaluation of the health effects of certain par-
ticulate compositions in ambient air requires long-term, 
multi-species measurements, which are difficult to apply in 
an epidemiological study. 
Susceptible populations. Environmental protection crite-
ria are in principle established based on integrated health 
risk assessment of the total population. However, epidemi-
ological studies have suggested that certain subgroup of the 
population, such as children, older, asthmatics, those with 
COPD or IHD, are more susceptible than others to the 
health effects of air pollution [5]. This susceptibility may be 
related to differences in physiological structure, immune 
level, exposure pattern, and underlying disease condition. 
For example, the World Health Organization indicates that 
children are potentially more susceptible to PM than adults 
because of their greater activity levels, time spent outdoors, 
and minute volume per unit body weight, all of which can 
increase the PM dose per lung surface area and have subse-
quent adverse effects on their developing lungs. In compar-
ison, the susceptibility of diabetic individuals to air pollu-
tion remains unclear and has attracted increased interest, 
which might be partially attributed to the association of PM  
with diabetes prevalence and various markers in plausible 
biological pathways. More population-based studies are 
needed to reveal the susceptibility of population subgroups 
to evaluate the health burden of ambient air pollution more 
accurately, and to implement specific control and preven-
tion measures for those susceptible to such pollution. 
The four dimensions of the variables summarized above 
will not only aid understanding of the complicated nature of 
PM2.5 health effects and identify the main PM2.5 size frac-
tion and chemical composition that cause the effects, but 
also provide comprehensive evidence in a broad perspective 
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